Largest pharmaceutical companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceutical companies ranked by total assets, at DKK 1B, followed by Erasca (DKK 2.7B) and Definium Therapeutics (DKK 3B). Figures as of 18 Nov 2026, 18:07 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsDKK 1B
- Median
- DKK 24B
- Combined market value
- DKK 34.7T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | DKK 1B | DKK 35.6B | DKK 843.68 | 1.36% down | 233% up | ||
| 2 | ErascaERAS · Health Care | DKK 2.7B | DKK 31.6B | DKK 90.13 | 4.68% down | 403% up | ||
| 3 | Definium TherapeuticsDFTX · Health Care | DKK 3B | DKK 26.9B | DKK 196.81 | 1.60% down | 169% up | ||
| 4 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 3.3B | DKK 56.1B | DKK 809.06 | 1.92% up | 13% up | ||
| 5 | Oruka TherapeuticsORKA · Health Care | DKK 3.3B | DKK 44.7B | DKK 659.19 | 0.53% up | 241% up | ||
| 6 | Dianthus TherapeuticsDNTH · Health Care | DKK 3.6B | DKK 33.4B | DKK 592.34 | 0.03% up | 113% up | ||
| 7 | Edgewise TherapeuticsEWTX · Health Care | DKK 3.8B | DKK 31.2B | DKK 285.01 | 0.42% down | 88% up | ||
| 8 | Travere TherapeuticsTVTX · Health Care | DKK 4.1B | DKK 33.3B | DKK 347.16 | 0.21% down | 44% up | ||
| 9 | ABIVAXABVX · Health Care | DKK 4.4B | DKK 49.9B | DKK 570.06 | 1.99% up | 27% down | ||
| 10 | Protagonist TherapeuticsPTGX · Health Care | DKK 4.5B | DKK 55.7B | DKK 853.82 | 0.60% up | 46% up | ||
| 11 | Axsome TherapeuticsAXSM · Health Care | DKK 4.7B | DKK 47.8B | DKK 908.73 | 1.81% down | 7% down | ||
| 12 | Summit TherapeuticsSMMT · Health Care | DKK 5.1B | DKK 57.7B | DKK 72.16 | 0.66% down | 36% down | ||
| 13 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | DKK 5.2B | DKK 50.8B | DKK 646.82 | 0.10% down | 126% up | ||
| 14 | Spyre TherapeuticsSYRE · Health Care | DKK 5.3B | DKK 62.4B | DKK 657.29 | 2.92% up | 286% up | ||
| 15 | Belite BioBLTE · Health Care | DKK 5.3B | DKK 43.7B | DKK 1,075.82 | 0.20% up | 31% up | ||
| 16 | Corcept TherapeuticsCORT · Health Care | DKK 5.7B | DKK 50.8B | DKK 464.56 | 2.61% down | 8% down | ||
| 17 | Mirum PharmaceuticalsMIRM · Health Care | DKK 5.7B | DKK 41.1B | DKK 629.99 | 0.64% up | 31% up | ||
| 18 | BridgeBio PharmaBBIO · Health Care | DKK 6.4B | DKK 103.6B | DKK 531.85 | 1.73% up | 17% up | ||
| 19 | Cogent BiosciencesCOGT · Health Care | DKK 6.4B | DKK 33.3B | DKK 191.16 | 0.83% up | 20% down | ||
| 20 | Praxis Precision MedicinesPRAX · Health Care | DKK 6.4B | DKK 58.4B | DKK 2,089.97 | 0.64% up | 61% up | ||
| 21 | TG TherapeuticsTGTX · Health Care | DKK 7.2B | DKK 67.8B | DKK 448.63 | 5.09% up | 107% up | ||
| 22 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 8.6B | DKK 64.2B | DKK 2,764.27 | 3.78% down | 24% down | ||
| 23 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 9.4B | DKK 41.9B | DKK 296.27 | 1.23% up | 10% up | ||
| 24 | CytokineticsCYTK · Health Care | DKK 9.7B | DKK 49.1B | DKK 352.23 | 0.17% up | 20% down | ||
| 25 | Ascendis PharmaASND · Health Care | DKK 9.8B | DKK 121.4B | DKK 1,851.50 | 0.29% up | 28% up | ||
| 26 | Ligand PharmaceuticalsLGND · Health Care | DKK 10.6B | DKK 40.9B | DKK 2,047.12 | 2.35% up | 43% up | ||
| 27 | Legend BiotechLEGN · Health Care | DKK 11.8B | DKK 21.4B | DKK 110.56 | 0.81% up | 42% down | ||
| 28 | InsmedINSM · Health Care | DKK 15.4B | DKK 180.5B | DKK 822.92 | 0.80% down | 40% down | ||
| 29 | AlkermesALKS · Health Care | DKK 16.9B | DKK 53.6B | DKK 319.01 | 3.10% up | 58% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | DKK 19.7B | DKK 34.3B | DKK 410.98 | 0.02% up | 20% down | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | DKK 24B | DKK 31.2B | DKK 187.08 | 1.93% up | 64% down | ||
| 32 | Amneal PharmaceuticalsAMRX · Health Care | DKK 25B | DKK 52.3B | DKK 150.04 | 4.36% up | 83% up | ||
| 33 | Alnylam PharmaceuticalsALNY · Health Care | DKK 33.8B | DKK 137.7B | DKK 1,027.76 | 3.53% down | 66% down | ||
| 34 | Roivant SciencesROIV · Health Care | DKK 38.9B | DKK 190.1B | DKK 262.37 | 0.44% down | 90% up | ||
| 35 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 42B | DKK 85.3B | DKK 102.35 | 1.66% up | 5% up | ||
| 36 | BioMarin PharmaceuticalBMRN · Health Care | DKK 51.7B | DKK 79.9B | DKK 412.48 | 3.55% up | 11% up | ||
| 37 | United TherapeuticsUTHR · Health Care | DKK 53.6B | DKK 168.7B | DKK 3,962.09 | 0.36% down | 23% up | ||
| 38 | BeOne MedicinesONC · Health Care | DKK 55.7B | DKK 315.3B | DKK 2,760.39 | 1.88% down | 17% up | ||
| 39 | Jazz PharmaceuticalsJAZZ · Health Care | DKK 79.4B | DKK 107.6B | DKK 1,676.40 | 2.30% up | 37% up | ||
| 40 | GenmabGMAB · Health Care | DKK 87.6B | DKK 216.2B | DKK 350.60 | 0.88% down | 70% up | ||
| 41 | Elanco Animal HealthELAN · Health Care | DKK 90.9B | DKK 91.7B | DKK 183.43 | 4.24% up | 20% up | ||
| 42 | ZoetisZTS · Health Care | DKK 105.3B | DKK 235.5B | DKK 579.64 | 1.99% up | 29% down | ||
| 43 | Royalty PharmaRPRX · Health Care | DKK 133.6B | DKK 271.3B | DKK 471.91 | 0.93% up | 78% up | ||
| 44 | GrifolsGRFS · Health Care | DKK 148.9B | DKK 39.2B | DKK 57.66 | 1.85% down | 1% up | ||
| 45 | Vertex PharmaceuticalsVRTX · Health Care | DKK 174.6B | DKK 928.6B | DKK 3,662.42 | 0.71% up | 27% up | ||
| 46 | ViatrisVTRS · Health Care | DKK 253.2B | DKK 161.4B | DKK 140.75 | 1.10% up | 96% up | ||
| 47 | Regeneron PharmaceuticalsREGN · Health Care | DKK 276.1B | DKK 667.9B | DKK 6,456.65 | 0.97% down | 36% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | DKK 277.4B | DKK 335.3B | DKK 287.35 | 0.96% down | 74% up | ||
| 49 | Novo NordiskNVO · Health Care | DKK 548.5B | DKK 1.19T | DKK 269.96 | 2.57% down | 17% down | ||
| 50 | GSKGSK · Health Care | DKK 552.3B | DKK 666.9B | DKK 332.73 | 0.74% down | 6% up | ||
| 51 | Abbott LaboratoriesABT · Health Care | DKK 590.3B | DKK 1.24T | DKK 713.24 | 0.06% up | 17% down | ||
| 52 | Bristol-Myers SquibbBMY · Health Care | DKK 613B | DKK 837.4B | DKK 409.65 | 1.92% down | 34% up | ||
| 53 | Takeda PharmaceuticalTAK · Health Care | DKK 661.3B | DKK 465.8B | DKK 145.79 | 1.04% down | 54% up | ||
| 54 | NovartisNVS · Health Care | DKK 755.3B | DKK 2.01T | DKK 1,063.09 | 1.87% down | 25% up | ||
| 55 | Eli LillyLLY · Health Care | DKK 765.7B | DKK 8.46T | DKK 9,502.15 | 1.40% down | 35% up | ||
| 56 | AstraZenecaAZN · Health Care | DKK 776.6B | DKK 1.9T | DKK 1,224.10 | 1.35% down | 2% up | ||
| 57 | AbbVieABBV · Health Care | DKK 912B | DKK 3.47T | DKK 1,962.67 | 1.54% down | 26% up | ||
| 58 | Merck & CoMRK · Health Care | DKK 931.7B | DKK 2.33T | DKK 946.31 | 3.04% down | 51% up | ||
| 59 | SanofiSNY · Health Care | DKK 957.8B | DKK 774.6B | DKK 322.58 | 0.31% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | DKK 1.36T | DKK 4.53T | DKK 1,879.95 | 0.91% down | 38% up | ||
| 61 | PfizerPFE · Health Care | DKK 1.42T | DKK 1.1T | DKK 192.11 | 0.88% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8077 DKK).
Questions and answers
Which pharmaceutical companies have the lowest total assets?
Veradermics (DKK 1B), Erasca (DKK 2.7B) and Definium Therapeutics (DKK 3B) have the lowest total assets of the 61 pharmaceutical companies ranked here as of 18 Nov 2026, 18:07 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by total assets.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by total assets have a combined market value of DKK 34.7T as of 18 Nov 2026, 18:07 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.